Cramer: The right way to play master limited partnerships

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

TPI Composites: "This is a tough one ... I see some big orders for wind. I am going to stay away from this one. I think that this is part of a complex that has already had its day, frankly."

Kinder Morgan: "KMI is an inexpensive stock now. I lost a lot of faith when they cut the dividend, but I can understand buying it. I think you'd rather have a basket of master limited partnerships, though."

Opko Health: "Opko Health recently ... it's not going to get reimbursed for one of its tests. Jeffries came out with an incredibly negative note about it. I remain faithful to Dr. Phil Frost, the CEO."

Ariad Pharmaceuticals: "I like Ariad. I think Ariad Pharma is very good. Remember, these are really speculative and a lot of speculation stocks have not worked out in the biotech area. But I do like it. I also like Radius, by the way."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com